EW

Edwards Lifesciences Corp (EW)

HealthcareMedical Devices
83.20USD
-0.83%
Magic Rank
#1245
Earnings Yield
2.9%
Return on Capital
25.8%
Market Cap
47.8B

Performance vs S&P 500 (5Y)

EW.US
S&P 500

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Magic Formula Analysis

Enterprise Value44.2B
Market / Universe
us
USA

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio44.82
Dividend YieldN/A
Debt to Equity-0.35
Gross Margin31.2%